PROTECT Data and Teplizumab in Newly Diagnosed T1D
- Author
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
- Published
- Wed 25 Oct 2023
- Episode Link
- https://audioboom.com/posts/8401895
In this episode, hosts discuss data from the PROTECT trial, which examined the effects of teplizumab on beta-cell function in patients with newly diagnosed type 1 diabetes.
